Pitavastatin Calcium Linked to 35% Reduced CVD Risk In People With HIV
April 14th 2023According to interim results from the REPRIEVE study, individuals with HIV who took the daily statin experienced a 35% reduced risk of major adverse cardiovascular (CVD) events, compared with those who received a placebo.
Read More
Governor Ron DeSantis signs 6-week abortion ban in Florida; Juul will pay Washington, DC, over $15 million as part of a settlement alleging the company marketed its products to teens; death counts attributed to malnutrition more than doubled from 2018 through 2022, with most deaths occurring to Californians 85 and older in 2022.
Read More
Sacubitril/Valsartan Likely to Improve Pre-HFpEF Outcomes vs Valsartan Alone
April 13th 2023At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient population.
Read More
What We’re Reading: Restricted Abortion Pill; Cigna Drug Price Transparency; New Parkinson Research
April 13th 2023Judges reverted steps to make abortion pill mifepristone more accessible, but it is still available; Cigna Group will be offering an option for members that allows more visibility into manufacturer drug pricing and discounts; new research on Parkinson disease could lead to new diagnostics and treatments.
Read More
Despite Potential Benefits, Barriers to CAR T-Cell Therapy for DLBCL Persist
April 13th 2023Chimeric antigen receptor (CAR) T-cell therapies have shown efficacy and safety for relapsed or refractory diffuse large B-cell lymphoma (DLBCL), but barriers to referral may obstruct patient access to them.
Read More
Ixazomib Shows PFS Benefit Across Age and Frailty Subgroups in Multiple Myeloma
April 12th 2023A secondary analysis of the phase 3 TOURMALINE-MM4 trial found that ixazomib as postinduction maintenance therapy for multiple myeloma produced a progression-free survival (PFS) benefit vs a placebo across age and frailty subgroups.
Read More
Association With Autoimmune Diseases Differs Between Epilepsy Types
April 12th 2023The researchers of a single-center study found that the relationships between epilepsy and autoimmune diseases may be a result of the different etiopathogenetic mechanisms that underly seizure development in each syndrome.
Read More